![]() |
|
|
Vol. 58, Issue 5, 1042-1049, November 2000
Departments of Psychopharmacology (A.N.-T., C.M., L.V., M.J.M.) and
Molecular and Cellular Pharmacology (V.A.), Institut de Recherches
Servier, Croissy-sur-Seine (Paris), France
ABSTRACT
This study evaluated the influence of receptor/G-protein (R:G)
stoichiometry on constitutive activity and the efficacy of agonists,
partial agonists, and inverse agonists at human (h) 5-hydroxytryphamine 1B (5-HT1B) receptors.
Two Chinese hamster ovary cell lines were used; they expressed 8.5 versus 0.4 pmol h5-HT1B receptors/mg (determined by
[3H]GR125,743 saturation analysis) and 3.0 versus
1.5 pmol receptor-activated G-proteins/mg [determined by
guanosine-5'-O-(3-[35S]thio)-triphosphate
([35S]GTP
S) isotopic dilution], respectively. Thus,
they displayed R:G ratios of ~3.0 (RGhigh) and ~0.3 (RGlow),
respectively. In competition-binding experiments, the agonists, 5-HT
and sumatriptan, displayed fewer high-affinity (HA)-binding sites and
the partial agonists, BMS181,101 and L775,606, displayed decreased
affinity in RGhigh versus RGlow membranes. In contrast, the inverse
agonists, SB224,289 and, to a lesser extent, methiothepin, showed
increased affinity. In G-protein activation experiments, both basal and 5-HT-activated [35S]GTP
S binding were higher in RGhigh
than in RGlow membranes. Constitutive activity (determined by
inhibition of basal [35S]GTP
S binding with GTP
S in
the absence of receptor ligands) was more pronounced in RGhigh versus
RGlow membranes, as revealed by the >5-fold greater proportion of HA
sites. Correspondingly, the negative efficacy of inverse agonists was
strikingly augmented, inasmuch as they suppressed approximately
two-thirds of HA [35S]GTP
S binding in RGhigh
membranes, but only approximately one-third in RGlow membranes.
Furthermore, the efficacy of partial agonists was greater at RGhigh
versus RGlow membranes, as estimated by their ability to enhance
[35S]GTP
S binding. In conclusion, an increase in R:G
ratios at h5-HT1B receptors was associated with an increase
in relative efficacy of partial agonists and, most notably, an increase
in both constitutive G-protein activation and negative efficacy of
inverse agonists.
This article has been cited by other articles:
![]() |
M. F. Peters, K. S. Knappenberger, D. Wilkins, L. A. Sygowski, L. A. Lazor, J. Liu, and C. W. Scott Evaluation of Cellular Dielectric Spectroscopy, a Whole-Cell, Label-Free Technology for Drug Discovery on Gi-Coupled GPCRs J Biomol Screen, April 1, 2007; 12(3): 312 - 319. [Abstract] [PDF] |
||||
![]() |
T. Kenakin Efficacy as a Vector: the Relative Prevalence and Paucity of Inverse Agonism Mol. Pharmacol., January 1, 2004; 65(1): 2 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zollner, M. A. Shaqura, C. P. Bopaiah, S. Mousa, C. Stein, and M. Schafer Painful Inflammation-Induced Increase in {micro}-Opioid Receptor Binding and G-Protein Coupling in Primary Afferent Neurons Mol. Pharmacol., August 1, 2003; 64(2): 202 - 210. [Abstract] [Full Text] [PDF] |
||||